India’s ageing population is creating a growing need for trained professionals who can provide medical, psychological, social and day-to-day support to senior citizens. As more elderly people require ...
Tavapadon, a treatment for Parkinson’s disease recently approved by the FDA, provides a novel option for healthcare providers ...
AbbVie presents 60 abstracts and presentations from a robust portfolio spanning across alopecia areata, atopic dermatitis, hidradenitis suppurativa, non-segmental vitiligo, psoriasis and psoriatic ...
FDA approves Juvmo (tavapadon), a selective D1/D5 receptor partial agonist, for Parkinson disease based on phase 3 TEMPO trial data.
FDA approves Tavapadon for Parkinson’s Disease in adults, offering new hope for symptom management. Discover what this means ...
India’s physiotherapy sector is expanding beyond post-injury care, driven by chronic diseases, ageing, sports injuries and ...
As wages stay stagnant, and inflation rises, many parents and grandparents who are able to, are gifting or loaning their ...
Welcome to DRI Healthcare Trust's Conference Call on the tavapadon transaction. Listeners are reminded that certain statements made in this conference call presentation, including responses to ...
IntroductionIn previous installments, we focused on changes in swallowing function due to aging itself. This time, we will shift our perspective to organize the representative underlying diseases that ...
An article for vets that recounts the events, treatments and conclusions in two occurrences of a rare disease.
It’s true. Rates of Parkinson’s disease are growing faster than any other neurological condition in the world, with incidence projected to double in the coming decades. Parkinson’s is a progressive ...
Whether you are battling high costs, long distances or stretching waitlists, many Australians have told us that accessing health care is becoming harder than ever.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results